We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine.
- Authors
Shaik, Riyaz Ahamed; Ahmad, Mohammed Shakil; Alzahrani, Mansour; Alzerwi, Nasser A. N.; Alnemare, Ahmad K.; Reyzah, Musaed; Albar, Haitham M.; Alshagrawi, Salah; Elkhalifa, Ahmed M. E.; Alzahrani, Raed; Alrohaimi, Yousef; Mahfoz, Turki M. Bin; Ahmad, Ritu Kumar; Alahmdi, Riyadh Ahmed; Al-baradie, Nora Raid Saleem
- Abstract
The world has taken proactive measures to combat the pandemic since the coronavirus disease 2019 (COVID-19) outbreak, which was caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). These measures range from increasing the production of personal protective equipment (PPE) and highlighting the value of social distancing to the emergency use authorization (EUA) of therapeutic drugs or antibodies and their appropriate use; nonetheless, the disease is still spreading quickly and is ruining people's social lives, the economy, and public health. As a result, effective vaccines are critical for bringing the pandemic to an end and restoring normalcy in society. Several potential COVID-19 vaccines are now being researched, developed, tested, and reviewed. Since the end of June 2022, several vaccines have been provisionally approved, whereas others are about to be approved. In the upcoming years, a large number of new medications that are presently undergoing clinical testing are anticipated to hit the market. To illustrate the advantages and disadvantages of their technique, to emphasize the additives and delivery methods used in their creation, and to project potential future growth, this study explores these vaccines and the related research endeavors, including conventional and prospective approaches.
- Subjects
SARS-CoV-2; COVID-19 vaccines; COVID-19; VACCINE development
- Publication
Vaccines, 2022, Vol 10, Issue 10, pN.PAG
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines10101689